Screening of esophagogastric varices: Performance of the “Expanded Baveno VI criteria” and the “platelet 150/MELD 6” strategy in all etiology compensated advanced chronic liver disease

Tosetti, Giulia; Mura, Vincenzo La; D’Ambrosio, Roberta; Degasperi, Elisabetta; Mezzina, Nicolò; Viganò, Mauro; Rumi, Maria Grazia; Fracanzani, A.L.; Lombardo, Rocco; Fraquelli, Mirella; Aghemo, Alessio; Lampertico, Pietro; Primignani, Massimo

doi:10.1016/j.dld.2018.01.074

Cited by 2 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The time interval between the index test and reference standard ranged from less than 24 hours to 12 months, but in most studies it was 12 months. Eighteen studies 33,35,38,[41][42][43][46][47][48][49][50][51][53][54][55][56][57][58] were reported in abstract form only.…”

Section: Resultsmentioning

confidence: 99%

“…Twenty-one studies were retrospective, 27,[30][31][32][35][36][37][38][39][40][41]43,44,47,[50][51][52][53]55,57,58 and hence did not use consecutive or random sampling of patients. All but 2 studies 37,59 did not report explicitly about prior knowledge of LSMs and platelet count by endoscopists.…”

Section: Quality Assessmentmentioning

confidence: 99%

“…Fifteen studies [31][32][33][35][36][37][38][40][41][42][43][44]47,52,53 were considered at high risk of bias because of an inappropriate time interval. Eleven studies 30,46,[48][49][50][51][54][55][56][57][58] provided no relevant details and were deemed at unclear risk of bias.…”

Section: Quality Assessmentmentioning

confidence: 99%

“…patients) provided data for HRVs and 14 studies27,31,32,[34][35][36]41,46,52,[54][55][56][57]59 (3000 patients) provided data for any size varices. Expanded Baveno VI criteria were assessed in 12 studies27,37,39,40,44,[48][49][50]52,53,59,60 …”

mentioning

confidence: 99%

See 3 more Smart Citations

Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Stafylidou

Paschos

Katsoula

et al. 2019

Clinical Gastroenterology and Hepatology

105

View full text Add to dashboard Cite

This article has an accompanying continuing medical education activity, also eligible for MOC credit, on page e109. Learning Objective-Upon completion of this activity, successful learners will be able to identify the appropriate test for screening and surveillance for esophageal varices in patients with compensated advanced chronic liver disease (cACLD). BACKGROUND & AIMS:We aimed to assess the accuracy of Baveno VI criteria for identification of high-risk varices (HRVs) and varices of any size in patients with compensated advanced chronic liver disease (cACLD). METHODS:We performed a systematic search of publications through December 2018 for studies that assessed the accuracy of Baveno VI criteria for screening for varices in patients with cACLD. We used hierarchical models to synthesize evidence. We also conducted a post hoc analysis to assess the accuracy of Expanded Baveno VI criteria. We appraised the confidence in estimates using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS:We identified 30 studies (8469 participants). Pooled values of Baveno VI criteria for HRVs (26 studies) were a sensitivity of 0.97 (95% CI, 0.95-0.98) and a specificity of 0.32 (95% CI, 0.26-0.39). Pooled sensitivity of Expanded Baveno VI criteria for HRVs (12 studies) was 0.90 (95% CI, 0.85-0.93) and specificity was 0.51 (95% CI, 0.45-0.57). In 1000 patients with cACLD, with a prevalence of HRVs of 20%, Baveno VI criteria would prevent endoscopy in 262 patients, but 6 patients with HRVs would be missed. Instead, use of the Expanded Baveno VI criteria would result in 428 patients avoiding endoscopy, but 20 patients with HRVs would be missed. The credibility of our findings is moderate or low, mainly owing to the retrospective design of most studies. CONCLUSIONS:Baveno VI criteria have high diagnostic accuracy as a triage test for screening for HRVs in patients with cACLD. Expanded Baveno VI criteria could reduce the proportion of unnecessary endoscopies further, nevertheless with a higher rate of missed HRVs.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Quality Assessmentmentioning

confidence: 99%

Section: Quality Assessmentmentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Stafylidou

Paschos

Katsoula

et al. 2019

Clinical Gastroenterology and Hepatology

105

View full text Add to dashboard Cite

show abstract

“…13 More recently, Augustin et al 14 explored the possibility of expanding the Baveno VI criteria, and showed that, by adopting a platelet value of 110,000/mm 3 and a liver stiffness threshold of <25 kPa, about 40% of endoscopies could be spared with a risk of missing only about 1.6% (95% CI 0-7-3.5%) of VNT. The performance of the extended Baveno VI criteria has been confirmed in two independent cohorts, in Spain and Great Britain, by Augustin et al 14 and in a further cohort in Italy by Tosetti et al 15 However, the vast majority of patients in whom the criteria were applied had cirrhosis of viral etiology, and only a small minority of patients had NAFLD. In addition, the M probe was used in most instances.…”

mentioning

confidence: 89%

Ruling out esophageal varices in NAFLD cirrhosis: Can we do without endoscopy?

Franchis

Krag

2018

Journal of Hepatology

View full text Add to dashboard Cite

Screening of esophagogastric varices: Performance of the “Expanded Baveno VI criteria” and the “platelet 150/MELD 6” strategy in all etiology compensated advanced chronic liver disease

Cited by 2 publications

References 0 publications

Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis

Ruling out esophageal varices in NAFLD cirrhosis: Can we do without endoscopy?

Contact Info

Product

Resources

About